Reliability of PSA circulating cells as markers of metastatic prostate cancer

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 64, Issue 7, 2004, Pages 687-690

  Cardillo, Maria Rosaria ^a   Di Silverio, Franco ^a   Gentile, Vincenzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

BLOOD SAMPLING; CANCER GRADING; CANCER LOCALIZATION; CANCER STAGING; CLINICAL PROTOCOL; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; EXON; GENE EXPRESSION; HORMONE INHIBITION; HUMAN; LETTER; MALE; MEDICAL LITERATURE; METASTASIS; ORCHIECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROSTATE SURGERY; PROSTATECTOMY; PUBLICATION; RELAPSE; RELIABILITY; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; TRANSURETHRAL RESECTION; VEIN PUNCTURE;

EID: 7044247728     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510410003101     Document Type: Letter

References (10)

1. Lintula S, Vesalainen S, Rannikko A, Zhang W-M, Finne P, Stenman J, Stenman U-H. Quantification of prostate specific antigen mRNA levels in circulation after prostatic surgery and endocrine treatment by quantitative reverse transcription-polymerase chain reaction. Scand J Clin Lab Invest 2004; 64: 93-100.
2. Martìnez-Pineiro L, Rios E, Martìnez-Gomariz M, Pastor T, de Cabo M, Picazo ML, Palacios J, Perona R. Molecular staging of prostatic cancer with RT-PCR assay for prostate-specific antigen in peripheral blood and lymph nodes: comparison with standard histological staging and immunohistochemical assessment of occult regional lymph node metastases. Eur Urol 2003; 43: 342-50.
3. Riegman PH, Klaassen P, van der Korput JA, Romijn JC, Trapman J. Molecular cloning and characterization of novel prostate antigen cDNAs. Biochem Biophys Res Commun 1988; 155: 181-8.
4. Nakajima-Jijima S, Hamada H, Reddy P, Kakunaga T. Molecular structure of human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns. Proc Natl Acad Sci USA 1985; 82: 6133-7.
5. Henke W, Jung M, Jung K, Lein M, Schlechte H, Berndt C, Rudolph B, Schnorr D, Loening SA. Increased analytical sensitivity of RT-PCR of PSA mRNA decreases of prostatic cells in blood, Int J Cancer 1997; 70: 52-6.
6. Ellis WJ, Pfitzenmaier J, Colli J, Arfman E, Lange PH, Vessella RL. Detection and isolation of prostate cancer cells from peripheral blood and bone marrow. Urology 2003;61:277-81.
7. Shariat SF, Kattan MW, Song W, Bernard D, Gottenger E, Wheeler M, Sloawin KM. Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen associated with prostate cancer progression in patients undergoing radical prostatectomy. Cancer Res 2003;63:5874-8.
8. Grasso Y, Gupta MK, Levin HS, Zippe CD, Klein EA. Combined nested RT-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in prostate cancer patients: correlation with pathological stage. Cancer Res 1998; 58: 1456-9.
9. Hara N, Kasahara T, Kawasaki T, Bilim V, Obara K, Takahaski K, Tomita Y. Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer. Clin Cancer Res 2002; 8: 1794-9.
10. Okegawa T, Noda H, Kato M, Miyata A, Nutahara K, Higashihara E. Value of reverse transcription polymerase chain reaction assay in pathological stage T3N0 prostate cancer. The Prostate 2000; 44: 210-8.